TNXP 1,38$ (-65%)

endpts.com/...phiii-ptsd-failure-sending-stock-to-the-gutter/

MK ~ 12 Mio. $

m.nasdaq.com/de/symbol/tnxp/real-time

www.fiercebiotech.com/biotech/...-take-data-from-phase-3-flop

Tonix plant 12 Mio. $ Kapitalerhöhung

www.sec.gov/Archives/edgar/data/1430306/...355/s112612_s1.htm

bin gespannt wie wiet es noch läuft :-)

Tonix Pharmaceuticals Announces Innovative Design in Next Phase 3 Study of Tonmya® for PTSD, Following FDA Meeting

NEW YORK, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at the 24th Annual BIO-Europe International Partnering Conference on Wednesday, November 7, 2018, in Copenhagen, Denmark.


Details of the presentation are as follows:

Event:   24th Annual BIO-Europe International Partnering Conference  
Date:   Wednesday, November 7, 2018  
Time:   11:30 a.m. CET  
Location:   Bella Center Copenhagen, Copenhagen, Denmark (Room B2 on level 0)  

finance.yahoo.com/news/...nces-patent-coverage-120000335.html

• Reverse Split von 1:10
• Kurs vor dem Split 0,42$ * 10 = 4,20$

seekingalpha.com/news/...mya-ptsd-shares-26-percent-premarket

die 3-3,50$

Equity Offering

www.sec.gov/Archives/edgar/data/1430306/...65/s114510_s1a.htm

seekingalpha.com/news/...9-tonix-pharma-111-percent-premarket